We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Versarien Plc | AQSE:VRS.GB | Aquis Stock Exchange | Ordinary Share | GB00B8YZTJ80 | Ordinary shares |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.039 | 0.029 | 0.049 | 0.039 | 0.039 | 0.039 | 0.00 | 06:40:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMVRS
RNS Number : 4187G
Versarien PLC
18 July 2023
18 July 2023
Versarien plc
("Versarien" or the "Company")
Directorate Changes
Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the appointment of Dr Stephen Hodge, currently the Company's Chief Technology Officer, as the Company's Chief Executive Officer with immediate effect.
Dr Stephen Hodge joined Versarien in 2017 and was appointed Head of Research in July 2018, before being appointed to the Board as Chief Technology Officer in January 2021. Prior to this, he was employed as a Principal Engineer at Cambridge Graphene Limited, a supplier of graphene inks and other graphene materials, and a subsidiary of Versarien. He has also held post-doctoral research associate positions at the Cambridge Graphene Centre, a research centre attached to the Department of Engineering at the University of Cambridge, and in the Department of Chemistry at Imperial College London, where he also completed a PhD in Nanomaterial Chemistry.
Stephen is a member of a number of advisory boards including holding the role of Chairman of the Technical Working Group within the Graphene REACH registration consortium. Last year Dr Hodge was awarded the Royal Society of Chemistry Rising Star in Industry Award 'for strategic leadership in developing greener solutions and advocating for global regulations related to the physical and toxicological testing of graphene'.
Resignation of Director
The Company has today received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the Company.
Diane Savory, Non-executive Chair of Versarien, commented:
"I am very pleased that we are announcing the appointment of Stephen Hodge as Versarien's Chief Executive Officer. Stephen has been with Versarien for the past six years during which time he has been instrumental in the development of the Company's advanced materials technology and progressing our commercial relationships. I believe he is ideally placed to lead the Company as we continue to progress our turnaround strategy and focus on the development and commercialisation of Cementene(TM) and Graphene-Wear(TM).
"On behalf of the Board I would like to thank Neill Ricketts for his contribution to the Company since its formation and we wish him well in his future endeavours.
"We look forward to updating shareholders on the continuing progress with our turnaround strategy in the coming months."
For further information please contact:
Versarien c/o IFC Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer SP Angel Corporate Finance (Nominated Adviser and Broker) +44 (0)20 3470 Matthew Johnson, Adam Cowl 0470 IFC Advisory Limited (Financial PR and Investor Relations) +44 (0) 20 3934 Tim Metcalfe, Zach Cohen 6630
About Versarien:
The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.
For further information please see : http://www.versarien.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOANKFBBPBKDFOD
(END) Dow Jones Newswires
July 18, 2023 11:31 ET (15:31 GMT)
1 Year Versarien Chart |
1 Month Versarien Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions